Skip to main content
. 2018 Jul 10;91(2 Suppl 1):S31–S37. doi: 10.1212/WNL.0000000000005790

Table 2.

Patient-reported outcome (PRO) tools considered for use in clinical trials of cutaneous neurofibromas (cNF)

graphic file with name NEUROLOGY2017854562t2.jpg